XML 47 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Other Balance Sheet Details (Tables)
12 Months Ended
Dec. 31, 2023
Other Balance Sheet Details [Abstract]  
Schedule of Inventory, Net
Inventory, net, consisted of the following:
December 31,
(in millions)20232022
Raw materials$21.5 $12.0 
Work in process9.7 5.6 
Finished goods12.3 17.5 
43.5 35.1 
Less inventory reserves
(5.2)— 
Total inventory, net
$38.3 $35.1 
Schedule of Property and Equipment
Property and equipment, net, consisted of the following:
December 31,
(in millions)20232022
Tenant improvements$38.1 $37.9 
Scientific equipment79.6 58.8 
Computer equipment25.2 21.5 
Furniture and fixtures10.9 6.7 
153.8 124.9 
Less accumulated depreciation(83.0)(66.3)
Total property and equipment, net$70.8 $58.6 
Schedule of Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consisted of the following:
December 31,
(in millions)20232022
Sales rebates and reserves$139.3 $131.9 
Accrued employee related costs86.2 72.8 
Current branded prescription drug fee45.7 27.5 
Accrued development costs44.3 39.1 
Current income taxes payable
24.4 9.0 
Accounts payable and other accrued liabilities108.9 67.3 
Total accounts payable and accrued liabilities$448.8 $347.6 
Schedule of Other Liabilities
Other long-term liabilities consisted of the following:
December 31,
(in millions)20232022
Noncurrent income taxes payable
$96.0 $19.8 
Noncurrent branded prescription drug fee
10.3 9.9 
Total other long-term liabilities
$106.3 $29.7 
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table presents a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
December 31,
(in millions)20232022
Cash and cash equivalents$251.1 $262.9 
Restricted cash8.0 7.8 
Total cash, cash equivalents and restricted cash$259.1 $270.7